$IPGP

Mammen Timothy PV sold $869K of IPGP

Mammen Timothy PV (SVP, Chief Financial Officer) sold 7,263 shares of IPG PHOTONICS CORP (IPGP) at $119.60 ($0.87M total) on 2026-05-22.

Original reporting
SEC EDGAR · Mammen Timothy PV
Published May 26, 2026, 9:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IPGP
Neutral
medium confidence
Mentioned
$IPGP
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPGPNeutralLow
01

Why it matters

Insider selling can be interpreted as caution, but without accompanying company-specific news, it is more useful as a sentiment/flow datapoint than a fundamental trigger.

02

Market read

Traders may monitor for clustering of insider sales or follow-through, but the article itself provides no fundamental update.

03

What to watch

Trade is small relative to typical institutional flows and lacks context on total compensation, other holdings, or whether additional insider trades occurred around the same period.

Relevance 6/10Timing: Immediate awareness for positioning, but not a standalone catalyst.

Background

The filing is an SEC Form 4 insider transaction by IPG Photonics’ CFO, reported after an open-market sale.

Company-level read

Ticker impact

$IPGPNeutralMedium confidence
Context

IPG Photonics CFO sold 7,263 shares in an open-market transaction totaling about $868.7K, disclosed via SEC Form 4.

Expected impact

Likely limited near-term impact; any reaction may fade unless follow-on selling or fundamental news emerges.

Evidence & confidence

This is a routine insider transaction disclosure with no accompanying operational or financial catalyst described in the article.

Market effects

Minimal; single-company insider sale without sector-wide signal.

None indicated; US-listed issuer only.

None indicated; no international transaction or guidance change mentioned.

Counterpoint

The sale may be for diversification, taxes, or pre-planned liquidity needs; absence of a 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • IPG Photonics Corp

    Subject of the insider transaction disclosure; CFO sold 7,263 shares for ~$868.7K.

  • Mammen Timothy PV

    SVP and Chief Financial Officer who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IPGPMedAI 8/10

Should IPG Photonics’ Q2 Earnings Beat And Tariff-Cautious Outlook Require Action From IPGP Investors?

IPG Photonics (IPGP) reported Q2 2026 adjusted earnings of $0.58 per share, beating expectations, with 11% YoY revenue growth driven by its Industrial Solutions segment. The company issued cautious Q3 guidance due to tariff uncertainty, but analyst estimates have recently increased. The company projects $1.4B revenue and $120M earnings by 2029, requiring 9.2% yearly revenue growth. A $100M share repurchase program is ongoing, though no shares were bought back in Q2. Tariff and trade risks remain

$IPGPMedAI 8/10

Why IPG Photonics Rallied Today

IPG Photonics (IPGP) shares rose 7.9% after the company reported mixed Q2 results and issued stronger-than-expected guidance. Revenue rose 11.1% to $278.6M, missing estimates, while adjusted EPS nearly doubled to $0.58. For Q3, IPG guided $280M revenue and $0.45 adjusted EPS at the midpoint.

$IPGPMed

IPG Photonics Q2 Earnings Call Highlights

IPG Photonics (IPGP) reported Q2 GAAP gross margin of 40.4% and adjusted gross margin of 40.7%, with GAAP diluted EPS of $0.12 and adjusted diluted EPS of $0.58. Management cited battery-manufacturing wins, additive manufacturing growth, and semiconductor momentum, plus CROSSBOW shipments for Lockheed Martin. IPG agreed to acquire Lumibird Medical, expected to close Q4 2026. Q3 revenue guidance is $265M to $295M.